Guggenheim Maintains Buy on RAPT Therapeutics, Lowers Price Target to $48
Guggenheim analyst Yatin Suneja maintains RAPT Therapeutics (NASDAQ:RAPT) with a Buy and lowers the price target from $55 to $48.
B of A Securities Upgrades Discover Finl to Neutral, Announces $107 Price Target
B of A Securities analyst Mihir Bhatia upgrades Discover Finl (NYSE:DFS) from Underperform to Neutral and announces $107 price target.
What’s Going On With Meta Platforms Stock Today?
Meta Platforms Inc (NASDAQ: META) shares are trading lower Wednesday even though several analysts raised price targets on the stock on the heels of CEO Mark Zuckerberg's
Barrington Research Reiterates Outperform on American Public Education, Lowers Price Target to $10
Barrington Research analyst Alexander Paris reiterates American Public Education (NASDAQ:APEI) with a Outperform and lowers the price target from $15 to $10.
Guggenheim Reiterates Buy on Larimar Therapeutics, Maintains $12 Price Target
Guggenheim analyst Yatin Suneja reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Buy and maintains $12 price target.
Goldman Sachs Maintains Neutral on Ecopetrol, Lowers Price Target to $11
Goldman Sachs analyst Bruno Amorim maintains Ecopetrol (NYSE:EC) with a Neutral and lowers the price target from $12.4 to $11.
EF Hutton Maintains Buy on BRT Apartments, Lowers Price Target to $25
EF Hutton analyst Gaurav Mehta maintains BRT Apartments (NYSE:BRT) with a Buy and lowers the price target from $27 to $25.
Wolfe Research Maintains Outperform on Meta Platforms, Raises Price Target to $230
Wolfe Research analyst Deepak Mathivanan maintains Meta Platforms (NASDAQ:META) with a Outperform and raises the price target from $220 to $230.
JP Morgan Maintains Overweight on New York Times, Raises Price Target to $41
JP Morgan analyst David Karnovsky maintains New York Times (NYSE:NYT) with a Overweight and raises the price target from $38 to $41.
Oppenheimer Reinstates Outperform on Darden Restaurants, Maintains $175 Price Target
Oppenheimer analyst Brian Bittner reinstates Darden Restaurants (NYSE:DRI) with a Outperform and maintains $175 price target.